Go to:
Logótipo
Comuta visibilidade da coluna esquerda
Você está em: Start > Publications > View > Pharmacophore-Based Screening as a Clue for the Discovery of New P-Glycoprotein Inhibitors
Publication

Publications

Pharmacophore-Based Screening as a Clue for the Discovery of New P-Glycoprotein Inhibitors

Title
Pharmacophore-Based Screening as a Clue for the Discovery of New P-Glycoprotein Inhibitors
Type
Article in International Conference Proceedings Book
Year
2010
Authors
palmeira, a
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
rodrigues, f
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
sousa, e
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
pinto, m
(Author)
FFUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page View ORCID page
vasconcelos, mh
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
fernandes, mx
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Conference proceedings International
Pages: 175-180
4th International workshop on Practical Applications of Computational Biology & Bioinformatics
Guimaraes, PORTUGAL, JUN 16-18, 2010
Other information
Authenticus ID: P-003-9Z8
Abstract (EN): The multidrug resistance (MDR) phenotype exhibited by cancer cells is believed to be hampering successful chemotherapy treatment in cancer patients. A group of ABC drug transporters which particularly include P-glycoprotein (Pgp) contribute to this phenotype. Thus, there is a need to anticipate whether drug candidates are possible Pgp substrates or noncompetitive inhibitors. Therefore, a pharmacophore model was created based on known Pgp inhibitors and it was used to screen a database of commercial compounds. After the screening, twenty-one candidate compounds were selected and their influence in the intracellular accumulation of Pgp substrate Rhodamine-123 (Rh123) was investigated by flow cytometry. Eleven compounds were found to significantly increase the accumulation of Rh123, four were found to decrease and six showed only a slight effect on the accumulation of Rh123. Furthermore, the competitive/non-competitive mechanism for the most promising compounds was determined by a luminescence Pgp's ATPase assay. Based on the cytometry results, a new pharmacophore was created for the Pgp inhibitory activity. The overall results provide important clues on how to proceed towards the discovery of Pgp inhibitors and which type of molecules merit further analysis.
Language: English
Type (Professor's evaluation): Scientific
Contact: mfx@uma.pt
No. of pages: 6
Documents
We could not find any documents associated to the publication.
Recommend this page Top
Copyright 1996-2025 © Faculdade de Direito da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z
Page created on: 2025-07-19 at 01:20:41 | Privacy Policy | Personal Data Protection Policy | Whistleblowing